1. Home
  2. FATE vs AKA Comparison

FATE vs AKA Comparison

Compare FATE & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • AKA
  • Stock Information
  • Founded
  • FATE 2007
  • AKA 2018
  • Country
  • FATE United States
  • AKA United States
  • Employees
  • FATE N/A
  • AKA N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • AKA Catalog/Specialty Distribution
  • Sector
  • FATE Health Care
  • AKA Consumer Discretionary
  • Exchange
  • FATE Nasdaq
  • AKA Nasdaq
  • Market Cap
  • FATE 133.0M
  • AKA 126.7M
  • IPO Year
  • FATE 2013
  • AKA 2021
  • Fundamental
  • Price
  • FATE $1.21
  • AKA $12.44
  • Analyst Decision
  • FATE Hold
  • AKA Buy
  • Analyst Count
  • FATE 8
  • AKA 4
  • Target Price
  • FATE $4.14
  • AKA $22.50
  • AVG Volume (30 Days)
  • FATE 1.8M
  • AKA 19.5K
  • Earning Date
  • FATE 05-13-2025
  • AKA 05-13-2025
  • Dividend Yield
  • FATE N/A
  • AKA N/A
  • EPS Growth
  • FATE N/A
  • AKA N/A
  • EPS
  • FATE N/A
  • AKA N/A
  • Revenue
  • FATE $13,335,000.00
  • AKA $586,514,000.00
  • Revenue This Year
  • FATE N/A
  • AKA $6.62
  • Revenue Next Year
  • FATE N/A
  • AKA $4.15
  • P/E Ratio
  • FATE N/A
  • AKA N/A
  • Revenue Growth
  • FATE 105.85
  • AKA 8.09
  • 52 Week Low
  • FATE $0.66
  • AKA $7.00
  • 52 Week High
  • FATE $5.92
  • AKA $32.25
  • Technical
  • Relative Strength Index (RSI)
  • FATE 53.44
  • AKA 56.33
  • Support Level
  • FATE $1.12
  • AKA $12.07
  • Resistance Level
  • FATE $1.38
  • AKA $12.91
  • Average True Range (ATR)
  • FATE 0.12
  • AKA 1.07
  • MACD
  • FATE 0.01
  • AKA 0.14
  • Stochastic Oscillator
  • FATE 62.22
  • AKA 56.68

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About AKA a.k.a. Brands Holding Corp.

a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.

Share on Social Networks: